Omega Fund Management, LLC Long-Term Concentrated

CIK: 0001637359 · Show all filings

Period: Q3 2021 (← Previous) (Next →)

Filing Date: Nov 15, 2021

Total Value ($000): $891,379 (100.0% shares, 0.0% debt)

Holdings (26)

NUVB Nuvation Bio 31.5%

Value ($000) $280,431 Shares 28,212,376 Est. Cost $11.18 Unrealized -18.9%

REPL Replimune Group 16.3%

Value ($000) $145,120 Shares 4,896,074 Est. Cost $17.40 Unrealized +86.7%

— Kronos Bio 9.0%

Value ($000) $80,031 Shares 3,818,283 Est. Cost $29.87 Unrealized —

— Morphic Holding 8.4%

Value ($000) $74,536 Shares 1,315,952 Est. Cost $19.82 Unrealized —

— Imago Biosciences 6.8%

Value ($000) $60,465 Shares 3,018,737 Est. Cost $20.03 Unrealized —

GOSS Gossamer Bio 4.7%

Value ($000) $41,740 Shares 3,320,608 Est. Cost $20.85 Unrealized -55.9%

— Ikena Oncology 3.2%

Value ($000) $28,384 Shares 2,249,123 Est. Cost $28.25 Unrealized —

IVVD Adagio Therapeutics 3.0%

Value ($000) $26,732 Shares 632,855 Est. Cost $37.11 Unrealized 0.0%

— Alpine Immune Sciences 2.4%

Value ($000) $21,656 Shares 2,029,580 Est. Cost $9.48 Unrealized —

SANA Sana Biotechnology, Inc. 2.1%

Value ($000) $19,001 Shares 843,750 Est. Cost $32.56 Unrealized -35.5%

IMUX Immunic Inc 1.8%

Value ($000) $15,825 Shares 1,788,160 Est. Cost $13.89 Unrealized -29.2%

ARQT Arcutis Biothereapeutics 1.7%

Value ($000) $14,903 Shares 623,836 Est. Cost $26.87 Unrealized -15.1%

— Spruce Biosciences 1.5%

Value ($000) $12,988 Shares 2,161,022 Est. Cost $24.31 Unrealized —

— Paratek Pharmaceuticals 1.4%

Value ($000) $12,669 Shares 2,606,809 Est. Cost $34.18 Unrealized —

— Icosavax 1.4%

Value ($000) $12,617 Shares 426,395 Est. Cost $29.59 Unrealized —

— Syros Pharmaceuticals 1.3%

Value ($000) $11,232 Shares 2,512,705 Est. Cost $8.72 Unrealized —

AVIR Atea Pharmaceuticals 0.6%

Value ($000) $5,770 Shares 164,577 Est. Cost $32.23 Unrealized -14.0%

— Checkmate Pharmaceuticals 0.6%

Value ($000) $5,300 Shares 1,335,050 Est. Cost $11.51 Unrealized —

— Omega Alpha SPAC 0.5%

Value ($000) $4,877 Shares 501,000 Est. Cost $9.98 Unrealized —

— Cidara Therapeutics 0.5%

Value ($000) $4,492 Shares 2,005,249 Est. Cost $5.64 Unrealized —

— ObsEva SA 0.3%

Value ($000) $3,108 Shares 999,364 Est. Cost $9.76 Unrealized —

— ESSA Pharma 0.3%

Value ($000) $2,626 Shares 328,196 Est. Cost $3.14 Unrealized —

— Jounce Therapeutics 0.2%

Value ($000) $2,047 Shares 275,513 Est. Cost $21.99 Unrealized —

IMCR Immunocore Holdings 0.2%

Value ($000) $1,910 Shares 51,535 Est. Cost $42.57 Unrealized —

TRVI Trevi Therapeutics 0.2%

Value ($000) $1,769 Shares 1,263,408 Est. Cost $8.20 Unrealized -78.4%

— FibroGen Inc 0.1%

Value ($000) $1,150 Shares 130,646 Est. Cost $27.34 Unrealized —

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
NUVB	Nuvation Bio	28,212,376	$280,431	31.5%	$11.18	-18.9%	Common Stock	67080N101
REPL	Replimune Group	4,896,074	$145,120	16.3%	$17.40	+86.7%	Common Stock	76029N106
—	Kronos Bio	3,818,283	$80,031	9.0%	$29.87	—	Common Stock	50107A104
—	Morphic Holding	1,315,952	$74,536	8.4%	$19.82	—	Common Stock	61775R105
—	Imago Biosciences	3,018,737	$60,465	6.8%	$20.03	—	Common Stock	45250K107
GOSS	Gossamer Bio	3,320,608	$41,740	4.7%	$20.85	-55.9%	Common Stock	38341P102
—	Ikena Oncology	2,249,123	$28,384	3.2%	$28.25	—	Common Stock	45175G108
IVVD	Adagio Therapeutics	632,855	$26,732	3.0%	$37.11	0.0%	Common Stock	00534A102
—	Alpine Immune Sciences	2,029,580	$21,656	2.4%	$9.48	—	Common Stock	02083G100
SANA	Sana Biotechnology, Inc.	843,750	$19,001	2.1%	$32.56	-35.5%	Common Stock	799566104
IMUX	Immunic Inc	1,788,160	$15,825	1.8%	$13.89	-29.2%	Common Stock	4525EP101
ARQT	Arcutis Biothereapeutics	623,836	$14,903	1.7%	$26.87	-15.1%	Common Stock	03969K108
—	Spruce Biosciences	2,161,022	$12,988	1.5%	$24.31	—	Common Stock	85209E109
—	Paratek Pharmaceuticals	2,606,809	$12,669	1.4%	$34.18	—	Common Stock	699374302
—	Icosavax	426,395	$12,617	1.4%	$29.59	—	Common Stock	45114M109
—	Syros Pharmaceuticals	2,512,705	$11,232	1.3%	$8.72	—	Common Stock	87184Q107
AVIR	Atea Pharmaceuticals	164,577	$5,770	0.6%	$32.23	-14.0%	Common Stock	04683R106
—	Checkmate Pharmaceuticals	1,335,050	$5,300	0.6%	$11.51	—	Common Stock	162818108
—	Omega Alpha SPAC	501,000	$4,877	0.5%	$9.98	—	Common Stock	G6749V107
—	Cidara Therapeutics	2,005,249	$4,492	0.5%	$5.64	—	Common Stock	171757107
—	ObsEva SA	999,364	$3,108	0.3%	$9.76	—	Common Stock	H5861P103
—	ESSA Pharma	328,196	$2,626	0.3%	$3.14	—	Common Stock	29668H708
—	Jounce Therapeutics	275,513	$2,047	0.2%	$21.99	—	Common Stock	481116101
IMCR	Immunocore Holdings	51,535	$1,910	0.2%	$42.57	—	Common Stock	45258D105
TRVI	Trevi Therapeutics	1,263,408	$1,769	0.2%	$8.20	-78.4%	Common Stock	89532M101
—	FibroGen Inc	130,646	$1,150	0.1%	$27.34	—	Common Stock	31572Q808